Navigation Links
Lilly Recognized as One of the World's Top Biopharmaceutical Employers
Date:10/10/2008

Science's Survey Criteria Included a Focus on Research and Respect for

People

INDIANAPOLIS, Oct. 10 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has made the list of Top 20 biopharmaceutical employers, according to the prestigious peer-reviewed journal Science. Science's 2008 survey polled nearly 4,000 employees from 500 employers in the biotechnology, biopharmaceutical, pharmaceutical and related industries. This year Lilly ranks number 10 on the list, up one position from last year's survey.

"At Lilly, our mission is to deliver innovative medicines for some of the world's most urgent unmet medical needs," said Steven Paul, M.D., executive vice president of science and technology, and president of Lilly Research Laboratories. "Core to our pipeline performance is the robust research environment here at Lilly, including excellence in both basic scientific and clinical research. Our world-renowned scientific talent has allowed Lilly to establish what we believe to be one of the best mid-stage pipelines in the industry, including 50 unique medicines - an all-time high for the company."

The web-based survey aims to determine the most reputable employers in the life science industries based on 23 characteristics, including among others, treating employees with respect, financial strength, easy adaptation to change, and a research-driven environment. The survey results appeared in today's issue of Science.

"It is an honor for Lilly to be recognized as one of the industry's top employers based on these important criteria," said John Lechleiter, Ph.D., Lilly president and chief executive officer. "Respect for people has always been a core value o
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Lilly Announces Termination of AIR Insulin Program
8. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Lilly Reports Solid First-Quarter Results
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...-IES(Nasdaq: IESC ),aleadingnationalproviderofelec...mercial,industrialandresidentialmarkets,announcedt...ontractfromManhattanTorconJVtoinstalltheelectrical...facilityattheU.S.ArmyMedicalResearchInstituteofInf...Md. ,, ThenewUSAMRIIDreplacementfacilitywilladd...
(Date:11/24/2009)...ment bank KTA Capital,s client Neuren Pharmaceutic...ible note private placement with a U.S. institutio...y KTA Capital as Neuren,s exclusive placement agen... (PRWEB) November 23, 2009 -- The independent New ...apital") has announced that its client Neuren...
(Date:11/24/2009)...ewswire-FirstCall/--DowAgroSciencesCanadaannounced...ofThompsonsLimitedofBlenheim,Ontario.Theadditionof...tseedsbusinessasthecompanyanticipatestheintroducti...bicideTolerantTraitTechnologyincornin2012.Thetrans...sacquisitionbringstogethertwostrongprogressivecomp...
(Date:11/24/2009)...--Sigma-AldrichCorporation(Nasdaq: SIAL )willbepre...stat1:45PMGMTinLondon,7:45AMUS/CST.Interestedparti...ilableat http://inve s tor.sig m a a ldrich...ile. ,, AboutSigma-Aldrich: Sigma-Aldrichisa...icalandbiochemicalproductsandkitsareusedinscientif...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...ompany Receives Initial $3.7 Million Distribution ...rmaceutical Co., Ltd., CHENGDU, China, March 17 /...ical, Co., Inc., (OTC Bulletin Board: TYNP), a man...hinese medicine (,TCM,) based in,Chengdu, China, t...FDA,approval and is scheduled to launch Azithromyc...
...EW HAVEN, Conn., March 17 VION,PHARMACEUTICALS, I...sults for,the fourth quarter and year-end of 2007....n, or $5.05 per share,for the year ended December ...n, or $3.83 per share, for 2006. Weighted-average ...mber 31, 2007 and December 31, 2006,were 6.7 milli...
... Canadian Biotechnology Company advances pharmaceu...harmaceutical opportunities - ...wire-FirstCall/ - SemBioSys Genetics Inc.,(TSX:SBS...of therapeutic,proteins for metabolic and cardiova...nd financial results for the twelve-month period e...
Other Biology Technology:Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets 2Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets 3Vion Reports 2007 Fourth Quarter and Year-End Results 2Vion Reports 2007 Fourth Quarter and Year-End Results 3Vion Reports 2007 Fourth Quarter and Year-End Results 4SemBioSys announces 2007 financial and operational results 2SemBioSys announces 2007 financial and operational results 3SemBioSys announces 2007 financial and operational results 4SemBioSys announces 2007 financial and operational results 5SemBioSys announces 2007 financial and operational results 6SemBioSys announces 2007 financial and operational results 7SemBioSys announces 2007 financial and operational results 8SemBioSys announces 2007 financial and operational results 9SemBioSys announces 2007 financial and operational results 10SemBioSys announces 2007 financial and operational results 11SemBioSys announces 2007 financial and operational results 12SemBioSys announces 2007 financial and operational results 13
(Date:11/23/2009)...lied mathematicians dissected the morphology of th...stic long leaf with a saddle-like arc midsection a...ple cause of the lily,s fan-like shapeelastic rela...growthwas revealed by using an equally simple tech... postdoctoral student at Harvard,s School of Engin...
(Date:11/23/2009)...ontrovertible evidence" that the volcanic super-er...00 years ago deforested much of central India, som...rt. , The volcano ejected an estimated 800 cubic...crater (now the world,s largest volcanic lake) tha...sh from the event has been found in India, the Ind...
(Date:11/23/2009)...microbiologist Louis Tisa has received two grants ...actinorhizal plants, widespread woody plants with ... soils. , The United States Department of Agric...ar, cellular and biomedical sciences, $399,000 to ...teria Frankia and Casuarina, an actinorhizal plant...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Fruit Even Healthier Than Thought 3A Study 56271 1Green Bridge Industries Inc to Exhibit ZAP 28TM 29 Stain Remover Pen at the L A County Fair 56267 1Green Bridge Industries Inc to Exhibit ZAP 28TM 29 Stain Remover Pen at the L A County Fair 56267 2New research strategy for understanding drug resistance in leukemia 56264 1New research strategy for understanding drug resistance in leukemia 56264 2New research strategy for understanding drug resistance in leukemia 56264 3
... The Senate Commission for the Investigation of H...e Forschungsgemeinschaft (DFG, German Research Fou...Values to the Federal Ministry for Labour and Soci...ute the set of recommendations for health protecti...ientific examination. 60 changes and additions to ...
... CHAMPAIGN, Ill. According to new research, old ...s on Earth, water also has been found in comets, o...ce. Now, scientists say this common fluid is not a...ow it, does not exist within our bodies," said Mar...or of Chemistry at the University of Illinois. "Wa...
... This press release is available in Spanish . ...ssue of the 1st of August the results of a detaile...rsity all through the last 50 million years. The s...f scientists from Australia, Spain, USA, UK, Holla...ve that the main concentrations of biodiversity ha...
Other Biology News:New and revised limits ensure safety in the workplace 2New and revised limits ensure safety in the workplace 3Water is 'designer fluid' that helps proteins change shape, scientists say 2Fossil and molecular evidence reveals the history of major marine biodiversity hotspots 2
...of the family of human cullin genes (CUL-1, -2, -3...ae cdc53 gene. Cullin-3 is proposed to be a part o...omplex with cyclin E and targets it for ubiquitina.... Cyclin E is an activator of cdk2, which leads th...
Imject Freund's Incomplete Adjuvant (FIA) from Pierce Biotechnology, Inc.
Tyrode's Salts solution from Sigma-Aldrich
Ellman's Reagent from Cayman Chemical
Biology Products: